The plant alkaloid piperine as a potential inhibitor of ethidium bromide efflux in Mycobacterium smegmatis

Journal of Medical Microbiology

Volumn 60, Issue 2, 2011, Pages 223-229

  Jin, G ^a   Zhang, Jiyu ^b   Guo, Na ^a   Feng, Haihua ^a   Li, Lei ^a   Liang, Junchao ^a   Sun, Kai ^a   Wu, Xiuping ^a   Wang, Xuelin ^a   Liu, Mingyuan ^a   Deng, Xuming ^a   Yu, Lu ^a  

^a JILIN UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CHLORPROMAZINE; ETHIDIUM BROMIDE; PIPERINE; RESERPINE; VERAPAMIL;

ARTICLE; ASSAY; CONTROLLED STUDY; FLUOROMETRY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ALKALOIDS; ANTI-BACTERIAL AGENTS; BENZODIOXOLES; BIOLOGICAL TRANSPORT; ENZYME INHIBITORS; ETHIDIUM; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM SMEGMATIS; PIPER; PIPER NIGRUM; PIPERIDINES; POLYUNSATURATED ALKAMIDES;

EID: 79251531348     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.025734-0     Document Type: Article

References (42)

1. Atal, C. K., Zutshi, U. & Rao, P. G. (1981). Scientific evidence on the role of ayurvedic herbals on bioavailability of drugs. J Ethnopharmacol 4, 229-232.
2. Atal, C. K., Dubey, R. K. & Singh, J. (1985). Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Ther 232, 258-262.
3. Badmaev, V., Majeed, M. & Norkus, E. P. (1999). Piperine, an alkaloid derived from black pepper, increases serum response of β-carotene during 14 days of oral β-carotene supplementation. Nutr Res 19, 381-388.
4. Bhardwaj, R. K., Glaeser, H., Becquemont, L., Klotz, U., Gupta, S. K. & Fromm, M. F. (2002). Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 302, 645-650.
5. Bigi, F., Alito, A., Romano, M. I., Zumarraga, M., Caimi, K. & Cataldi, A. (2000). The gene encoding P27 lipoprotein and a putative antibiotic-resistance gene form an operon in Mycobacterium tuberculosis and Mycobacterium bovis. Microbiology 146, 1011-1018.
6. Bloom, B. R. & Murray, C. J. (1992). Tuberculosis: commentary on a reemergent killer. Science 257, 1055-1064.
7. Chacon, O., Feng, Z., Harris, N. B., Cáceres, N. E., Adams, L. G. & Barletta, R. G. (2002). Mycobacterium smegmatis D-alanine racemase mutants are not dependent on D-alanine for growth. Antimicrob Agents Chemother 46, 47-54.
8. NCCLS (2003). Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes, approved standard M24-A. Wayne, PA: National Committee for Clinical Laboratory Standards.
9. Coldham, N. G., Webber, M., Woodward, M. J. & Piddock, L. J. (2010). A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli. J Antimicrob Chemother 65, 1655-1663.
10. Couto, I., Costa, S. S., Viveiros, M., Martins, M. & Amaral, L. (2008). Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide. J Antimicrob Chemother 62, 504-513.
11. De Rossi, E., Ainsa, J. A. & Riccardi, G. (2006). Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol Rev 30, 36-52.
12. Eilam, Y. (1983). Membrane effects of phenothiazines in yeasts. I. Stimulation of calcium and potassium fluxes. Biochim Biophys Acta 733, 242-248.
13. EUCAST-ESCMID (2000). EUCAST Definitive Document E.Def 1.2, May 2000. Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin Microbiol Infect 6, 503-508.
14. Farrow, M. F. & Rubin, E. J. (2008). Function of a mycobacterial major facilitator superfamily pump requires a membrane-associated lipoprotein. J Bacteriol 190, 1783-1791.
15. Flores, A. R., Parsons, L. M. & Pavelka, M. S., Jr (2005). Genetic analysis of the β-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to β-lactam antibiotics. Microbiology 151, 521-532.
16. Gibbons, S., Oluwatuyi, M. & Kaatz, G. W. (2003). A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J Antimicrob Chemother 51, 13-17.
17. Gupta, A. K., Chauhan, D. S., Srivastava, K., Das, R., Batra, S., Mittal,M., Goswami, P., Singhal, N., Sharma, V. D. & other authors (2006). Estimation of efflux mediated multi-drug resistance and its correlation with expression levels of two major efflux pumps in mycobacteria. J Commun Dis 38, 246-254.
18. Jennings, B. R. & Ridler, P. J. (1983). Interaction of chromosomal stains with DNA. An electrofluorescence study. Biophys Struct Mech 10, 71-79.
19. Kaatz, G. W., Moudgal, V. V., Seo, S. M. & Kristiansen, J. E. (2003). Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother 47, 719-726.
20. Khan, I. A., Mirza, Z. M., Kumar, A., Verma, V. & Qazi, G. N. (2006). Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrob Agents Chemother 50, 810-812.
21. Kumar, A., Khan, I. A., Koul, S., Koul, J. L., Taneja, S. C., Ali, I., Ali, F., Sharma, S., Mirza, Z. M. & other authors (2008). Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus. J Antimicrob Chemother 61, 1270-1276.
22. Lechner, D., Gibbons, S. & Bucar, F. (2008). Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis. J Antimicrob Chemother 62, 345-348.
23. Lewis, K. (1999). Multidrug resistance: versatile drug sensors of bacterial cells. Curr Biol 9, R403-R407.
24. Lomovskaya, O., Zgurskaya, H. I., Totrov, M. & Watkins, W. J. (2007). Waltzing transporters and 'the dance macabre' between humans and bacteria. Nat Rev Drug Discov 6, 56-65.
25. Marquez, B. (2005). Bacterial efflux systems and efflux pumps inhibitors. Biochimie 87, 1137-1147.
26. Martins, A., Spengler, G., Rodrigues, L., Viveiros, M., Ramos, J., Martins, M., Couto, I., Fanning, S., Pagès, J. M. & other authors (2009). pH modulation of efflux pump activity of multi-drug resistant Escherichia coli: protection during its passage and eventual colonization of the colon. PLoS ONE 4, e6656.
27. Mohtar, M., Johari, S. A., Li, A. R., Isa, M. M., Mustafa, S., Ali, A. M. & Basri, D. F. (2009). Inhibitory and resistance-modifying potential of plant-based alkaloids against methicillin-resistant Staphylococcus aureus (MRSA). Curr Microbiol 59, 181-186.
28. Odds, F. C. (2003). Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52, 1.
29. Oluwatuyi, M., Kaatz, G. W. & Gibbons, S. (2004). Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry 65, 3249-3254.
30. Rodrigues, L.,Wagner, D., Viveiros, M., Sampaio, D., Couto, I., Vavra,M., Kern, W. V. & Amaral, L. (2008). Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis. J Antimicrob Chemother 61, 1076-1082.
31. Sharma, P., Varma, M. V., Chawla, H. P. & Panchagnula, R. (2005). In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies. Farmaco 60, 874-883.
32. Sharma, S., Kumar, M., Sharma, S., Nargotra, A., Koul, S. & Khan, I. A. (2010). Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis. J Antimicrob Chemother 65, 1694-1701.
33. Sharples, D. & Brown, J. R. (1976). Correlation of the base specificity of DNA-intercalating ligands with their physico-chemical properties. FEBS Lett 69, 37-40.
34. Singh, J., Dubey, R. K. & Atal, C. K. (1986). Piperine-mediated inhibition of glucuronidation activity in isolated epithelial cells of the guinea-pig small intestine: evidence that piperine lowers the endogenous UDP-glucuronic acid content. J Pharmacol Exp Ther 236, 488-493.
35. Stavri, M., Piddock, L. J. & Gibbons, S. (2007). Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother 59, 1247-1260.
36. Tegos, G. P., Masago, K., Aziz, F., Higginbotham, A., Stermitz, F. R. & Hamblin, M. R. (2008). Inhibitors of bacterial multidrug efflux pumps potentiate antimicrobial photoinactivation. Antimicrob Agents Chemother 52, 3202-3209.
37. Thota, N., Koul, S., Reddy, M. V., Sangwan, P. L., Khan, I. A., Kumar, A., Raja, A. F., Andotra, S. S. & Qazi, G. N. (2008). Citral derived amides as potent bacterial NorA efflux pump inhibitors. Bioorg Med Chem 16, 6535-6543.
38. Victor, T. C., van Helden, P. D. & Warren, R. (2002). Prediction of drug resistance in M. tuberculosis: molecular mechanisms, tools, and applications. IUBMB Life 53, 231-237.
39. Viveiros, M., Leandro, C. & Amaral, L. (2003). Mycobacterial efflux pumps and chemotherapeutic implications. Int J Antimicrob Agents 22, 274-278.
40. Werle, M. (2008). Polymeric and low molecular mass efflux pump inhibitors for oral drug delivery. J Pharm Sci 97, 60-70.
41. WHO (2000). Anti-tuberculosis Drug Resistance in the World. Report no. 2: Prevalence and Trends, WHO/CDS/TB/2000.278. Geneva: World Health Organization.
42. WHO (2009). Global Tuberculosis Control 2009: Epidemiology, Strategy, Financing, WHO/HTM/TB/2009.411. Geneva: World Health Organization.